Basigin in cerebrovascular diseases: Roles, mechanisms, and therapeutic target potential
European Journal of Pharmacology · 2025
DOI: 10.1016/j.ejphar.2024.177232 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Pharmacology, 2025. Verfasst von Qi Qin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Zhengzhou City, Henan Province, 450000, Ch…. Hauptthemen laut MEDLINE: Basigin, Cerebrovascular Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 122 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science, Technology and Innovation Commission of Shenzhen Municipality.
Abstract (Originalsprache)
Cerebrovascular diseases are major global health issues, responsible for significant morbidity and mortality. Basigin (additionally called CD147 or EMMPRIN) is a glycosylated transmembrane protein that facilitates intercellular communication. Recent research has highlighted the critical role of Basigin in inducing matrix metalloproteinases (MMPs), which contribute to the progression of cerebrovascular diseases. Consequently, Basigin has emerged as a promising therapeutic target for these conditions. However, inhibiting the pivotal role of Basigin in mediating cerebrovascular disease is an urgent area of investigation. In this review, we systematically examine the pathological mechanisms by which Basigin contributes to the development of cerebrovascular diseases. We present evidence demonstrating the protective effect of targeted inhibition of Basigin in these conditions and suggest future research directions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Zhengzhou City, Henan Province, 450000, China.
- Emergency Department, Shenzhen Traditional Chinese Medicine Hospital, The fourth Clinical Medical College of Guangzhou University of Chinese Medicine, No.1 Fuhua Road, Shenzhen City, Guangdong Province, 518033, China.
- Institute of Medicine, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Nanshan District, Shenzhen City, Guangdong Province, 518055, China. Electronic address: yz.ma@siat.ac.c…
- Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Zhengzhou City, Henan Province, 450000, China. Electronic address: fccliuxz@zzu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Science, Technology and Innovation Commission of Shenzhen Municipality
Zitieren
APA
Qin, Q., Feng, M., Zhang, K., Mo, Z., Liu, Y., Ma, Y., & Liu, X. (2025). Basigin in cerebrovascular diseases: Roles, mechanisms, and therapeutic target potential. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2024.177232
Vancouver
Qin Q, Feng M, Zhang K, Mo Z, Liu Y, Ma Y, et al. Basigin in cerebrovascular diseases: Roles, mechanisms, and therapeutic target potential. European Journal of Pharmacology. 2025. doi:10.1016/j.ejphar.2024.177232
BibTeX
@article{Qin2025,
author = {Qin, Qi and Feng, Mengzhao and Zhang, Kaiyuan and Mo, Zhizhun and Liu, Yuxiang and Ma, Yinzhong and Liu, Xianzhi},
title = {Basigin in cerebrovascular diseases: Roles, mechanisms, and therapeutic target potential},
journal = {European Journal of Pharmacology},
year = {2025},
doi = {10.1016/j.ejphar.2024.177232}
}
EUVIMED